Colorectal Surgery, Third Affiliated Hospital of Kunming Medical University, Tumor Hospital of Yunnan Province, Kunming, Yunnan 650118, China.
Oncology, Taikang Tongji (Wuhan) Hospital, Wuhan, Hubei 430051, China.
Dis Markers. 2019 Nov 20;2019:8023460. doi: 10.1155/2019/8023460. eCollection 2019.
CXCL8 (also known as IL-8) can produce different biological effects by binding to its receptors: CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC). CXCL8 and its receptors are associated with the development of various tumor types, especially colorectal cancer and its liver metastases. In addition to promoting angiogenesis, proliferation, invasion, migration, and the survival of colorectal cancer (CRC) cells, CXCL8 and its receptors have also been known to induce the epithelial-mesenchymal transition (EMT) of CRC cells, to help them to escape host immunosurveillance as well as to enhance resistance to anoikis, which promotes the formation of circulating tumor cells (CTCs) and their colonization of distant organs. In this paper, we will review the established roles of CXCL8 signaling in CRC and discuss the possible strategies of targeting CXCL8 signaling for overcoming CRC drug resistance and cancer progression, including direct targeting of CXCL8/CXCR1/2 or indirect targeting through the inhibition of CXCL8-CXCR1/2 signaling.
CXCL8(也称为 IL-8)可以通过与其受体:CXCR1、CXCR2 和趋化因子 Duffy 抗原受体(DARC)结合来产生不同的生物学效应。CXCL8 及其受体与各种肿瘤类型的发展有关,特别是结直肠癌及其肝转移。除了促进血管生成、增殖、侵袭、迁移和结直肠癌细胞(CRC)的存活外,CXCL8 及其受体还被认为可以诱导 CRC 细胞的上皮-间充质转化(EMT),帮助它们逃避宿主免疫监视,并增强对 anoikis 的抵抗能力,从而促进循环肿瘤细胞(CTC)的形成及其对远处器官的定植。在本文中,我们将回顾 CXCL8 信号在 CRC 中的作用,并讨论靶向 CXCL8 信号以克服 CRC 耐药性和癌症进展的可能策略,包括直接靶向 CXCL8/CXCR1/2 或通过抑制 CXCL8-CXCR1/2 信号间接靶向。